Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded multiple Federal Supply Schedule (FSS) contracts and Blanket Purchase Agreements (BPAs) by the Department of Veterans Affairs (VA) Veterans Health Administration to provide in vitro diagnostic products, reagents, and services. The contracts, valued up to $11.4 million, utilize the Invitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule and typically involve firm fixed price delivery orders for items such as COVID-19 test kits, reagents for clinical analyzers, viral load testing, and HIV/Hepatitis C reagents. Abbott Molecular has also been awarded several sole source BPA contracts worth over $13 million to supply the VA with proprietary Alinity M molecular diagnostic analyzers, reagents, and consumables on an indefinite delivery basis. The contracted products and services are intended to enhance the VA's diagnostic testing capabilities and support the healthcare needs of veteran patients across the country.
Generated 3/26/24, 6:38 PM